Similarly, although pioglitazone reduces tissue loss and cognitive impairment after TBI by PPARγ activation, this drug reduces microglial activation via a PPARγ-independent mechanism (Sauerbeck et al., 2011). Here, PPARG is linked to Cognitive impairment.